Harnessing the Power of Atrial-Specific Cardiomyocytes for Enhanced Drug Discovery Studies

Learning objectives:

• Discover the quality of our latest cell model: Ncyte® aCardiomyocytes
  
  
• Learn about the advantages of using chamber-specific cardiomyocytes in your drug screening studies
  
  
• Go through a case study to gain insights on their applications for toxicity and gene modulation

Leveraging our extensive expertise in stem cell biology and cell manufacturing, we have recently introduced a new cell model to our portfolio: the Ncyte® aCardiomyocytes - Human iPSC-derived atrial cardiomyocytes with the highest quality and reproducibility in every batch.

In this webinar, we will provide details on the quality control and characterization of Ncyte® aCardiomyocytes, as well as examples of their applications in drug discovery and the advantages of using chamber-specific cardiomyocytes.

Ncyte® aCardiomyocytes are ideal for developing assay platforms to screen structural toxicity across various drug panels, or for gene modulation assays. As a case study, we show how these cells have been effectively used to screen anti-cancer drugs and explore their mechanisms of action through a variety of downstream assays.

Meet our Speakers: